Repository logo

Browsing by Person "Furin, J."

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Building social equity and person-centred innovation into the end TB response [Letter to the editor]
    (International Union Against Tuberculosis and Lung Disease, 2024-11-01) Engel, N.; Apolosi, I.; Bhargava, A.; Bhan, A.; Celan, C.; Mak, A.; Chikovore, J.; Chorna, Y.; Claassens, M.M.; Dagron, S.; Denholm, J.T.; Frick, M.; Furin, J.; Hoddinott, G.; Kashnitsky, D.; Kielmann, Karina; Kunor, T.; Lin, D.; McDowell, A.; Mitchell, E.M.; Oga-Omenka, C.; Samina, P.; Shikoli, S.A.; Silva, D.S.; Stein, R.; Stillo, J.; van der Westhuizen, H.M.; Wingfield, T.; Zwerling, A.; Daftary, A.
    Reducing systemic inequities in testing, access to care, social protection – and in the scientific process – is essential to end TB. Incorporating social science methods and expertise on inequity into the mainstream TB response would help ensure that political commitments to equity move beyond symbolic gestures. We convened a meeting between TB social scientists, people with lived experience, civil society and community members to discuss equity within the global TB response. Here, we propose five means by which a social science lens can strengthen equitable, person-centred responses and reconcile the public health significance of TB with the principles of social justice.
  • Thumbnail Image
    Item
    'I'm fed up': Experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIV
    (International Union Against Tuberculosis and Lung Disease, 2014-12-01) Furin, J.; Isaakidis, P.; Reid, A. J.; Kielmann, Karina
    OBJECTIVES: To understand the impact of past experiences of anti-tuberculosis treatment among patients co-infected with the human immunodeficiency virus and multidrug-resistant tuberculosis (MDR-TB) on perceptions and attitudes towards treatment. METHODS: Qualitative study using in-depth interviews with 12 HIV-MDR-TB co-infected patients in Mumbai, India. RESULTS: Patients reported unnecessarily long pathways to care and fatigue with diagnostic and treatment procedures. In particular, they expressed concerns over the lack of efficacy of their current treatment regimen based on their experiences with anti-tuberculosis treatment regimens in the past. CONCLUSION: Patients reported negative experiences with previous HIV and anti-tuberculosis treatment. Access to early diagnosis and rapid initiation of integrated care for HIV-MDR-TB co-infected patients, with a strong, patient-centered support system, could help to combat the low morale and lack of faith in treatment described in this group of patients.